Smithfield Trust’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,802
Closed -$85K 1072
2022
Q3
$85K Sell
1,802
-460
-20% -$29.7K 0.01% 421
2022
Q2
$160K Buy
2,262
+136
+6% +$9.94K 0.01% 324
2022
Q1
$173K Sell
2,126
-1,043
-33% -$88.2K 0.01% 336
2021
Q4
$325K Buy
3,169
+158
+5% +$15.2K 0.02% 246
2021
Q3
$263K Buy
3,011
+1,459
+94% +$132K 0.02% 267
2021
Q2
$139K Hold
1,552
0.01% 381
2021
Q1
$118K Buy
+1,552
New +$117K 0.01% 413
2020
Q2
Sell
-130
Closed -$5K 1111
2020
Q1
$5K Buy
+130
New +$7.6K ﹤0.01% 793

Other funds holding SYNH

Smithfield Trust's SYNH Position: Q4 2022 in Review

Smithfield Trust sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 1,802 shares — an estimated $85K sold.

Smithfield Trust first reported a position in SYNH in Q1 2020 and held it in 8 quarters. The position peaked at $325K in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Smithfield Trust reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Smithfield Trust sold 1,802 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $85K.
  • Smithfield Trust first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 8 quarters.
  • Smithfield Trust's Syneos Health, Inc. Class A Common Stock position peaked at $325K in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Smithfield Trust's 13F filing for Q4 2022, filed 13 Feb 2023.